Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
about
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cellsResistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacinOfloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriaDevelopment of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJRole of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosaOuter membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacinMechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.Broad-host-range gyrase A gene probe.Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusDose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.Resistance to pefloxacin in Pseudomonas aeruginosa.Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrAPersistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.A review of the antimicrobial activity of the fluoroquinolones.Quinolone antimicrobial agents: adverse effects and bacterial resistance.Structure-activity relationships of the fluoroquinolones.In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.Biological properties of structurally related alpha-helical cationic antimicrobial peptides.Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parCOuter membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosaNew norfloxacin resistance gene in Pseudomonas aeruginosa PAO.Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.
P2860
Q24676018-D2CCD707-A981-48B4-843A-70FABF9398DDQ33742745-3B2857EF-61BF-4A7E-B0FA-051199DD9C11Q33756446-8E751AD8-BA8A-46ED-A58C-4CD1CC4025B8Q33980505-0E247E50-C3CE-40AC-98E4-60292050E903Q34010692-AE949AD8-B8F8-4129-86A7-70CDCB8EAB97Q35111809-B34C830F-52CA-4434-85CA-C8E98278A819Q35117101-612984D4-A30E-4AC3-86D1-88453F128133Q35119495-A4483CBD-38E7-420D-8AF8-ADA802574673Q35120124-E6A7A051-49A7-49B0-8107-A2A6C78488D7Q35243870-B0559B5A-27AE-44FE-9A6B-0D8A70888F44Q35244676-6B899E1B-36DA-44C2-AFA4-103487D30A83Q35248719-0EDE3666-D215-499F-9665-53CE52B8136AQ35276491-AC9677E2-8562-4FA7-9268-4924A92044EDQ35359592-289C67DC-9D90-4B75-97A3-ED0C6D9C47B4Q35816058-12D87464-6ACE-43CF-B300-871FB641ECBDQ35818681-0CEABE70-42B0-4534-8CA4-F3DA98E44B2CQ35836280-C85F48B5-F26B-4227-81CF-B7F4487C4F77Q35893473-407B55DA-B334-45AD-8648-E90B14CB1CADQ36123973-7F0286FC-569B-4B2C-BC53-76755A8C56C4Q36574542-FBA86C6C-4C5F-47FB-9491-2FCA5D2AB76EQ36752823-C5C3512B-FE9A-4C2D-85A5-D148D8F1EBB0Q36753117-57B391D3-F331-4386-AFB9-A90C24723AD9Q36753750-3D438EB8-2E56-4335-B85F-669F93D0191BQ36754434-1C99F02B-8E2E-4023-AB68-8933A3300193Q37834318-B7A3A3A2-8F26-4408-B4E7-0820511159D5Q38322827-659DD238-C50D-48DE-9434-6F44677373A1Q38629697-DECEEB96-F229-4144-8FA8-90707131DD10Q39469750-4B589A81-DD3D-40F1-97C0-BD492B4AFC4CQ39469894-C357D094-26EC-488E-BF11-36118EF8209BQ39510622-850B7F40-10A9-4368-927E-050AB6332D04Q39559711-7BB33F55-597F-453C-97A9-CDD024E492C4Q39779320-057C6921-FDAA-4AD9-8105-7134C62E3B0EQ39779448-B28FCE2C-A4A9-4E5E-9D3B-3E6B85FAB611Q39816347-E9FFFE05-9EF2-41B4-98B5-2117234F2FF2Q39816779-6E9BAC10-DFD1-4BAC-8A12-9855DB6D4FBBQ39817132-7DD19ED5-45E1-4A23-B100-DF0B60CB78A7Q39819149-5C23F591-195A-44A8-94D5-440480408E5CQ39819849-1F602ACB-F598-4E96-B11B-0E06B87D86DAQ39875903-AB6E7F21-8B34-48D4-9D49-6E1FBDD23593Q39881769-2C81D982-E5D3-4B1B-BEA8-742827DC9CB7
P2860
Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@ast
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@en
type
label
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@ast
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@en
prefLabel
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@ast
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@en
P2860
P356
P1476
Genetic and physiological char ...... in Pseudomonas aeruginosa PAO.
@en
P2093
Robillard NJ
P2860
P304
P356
10.1128/AAC.32.4.535
P407
P577
1988-04-01T00:00:00Z